Suvanza Pharma, LLC (SUVZ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 23, 2026
Suvanza Pharma, LLC Market Cap
Suvanza Pharma, LLC has a market cap or net worth of $2.24 thousand as of October 16, 2026. It is the 52,216th most valuable company in the world and the 8,257th biggest in the United States. Its market cap has increased by 99.91% in one year.
Market Cap
2.24K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,257 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 10, 2010, Suvanza Pharma, LLC's market cap has increased from 1.12K to 2.24K, an increase of 99.91%. That is a compound annual growth rate of 4.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 2.24K | - |
| Sep 24, 2025 | 2.24K | - |
| Aug 5, 2025 | 2.24K | 99.91% |
| Sep 21, 2021 | 1.12K | -99.80% |
| May 4, 2021 | 559.85K | - |
| Mar 29, 2021 | Upgrade Pro | Upgrade Pro |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
| Mar 12, 2021 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
| Feb 10, 2021 | Upgrade Pro | Upgrade Pro |
| Sep 15, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 23, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 1, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Synovics Pharmaceuticals | 3.65K |
| Anthera Pharmaceuticals | 3.53K |
| Rebus Holdings | 3.21K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| Lipella Pharmaceuticals | 2.77K |
| Innoveren Scientific | 2.40K |
| OncoVista Innovative Therapies | 2.36K |